DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 13D and 13G filings for Acorda Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-05-10 4:37 pm Sale | 2023-05-08 | 13D | Acorda Therapeutics, Inc. ACOR | DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 55,144 4.530% | -35,009 (-38.83%) | Filing |
| 2023-03-10 4:15 pm Sale | 2023-03-08 | 13D | Acorda Therapeutics, Inc. ACOR | DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 90,154 7.410% | -13,985 (-13.43%) | Filing |
| 2023-01-23 4:30 pm Sale | 2023-01-19 | 13D | Acorda Therapeutics, Inc. ACOR | DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 104,138 8.560% | -16,027 (-13.34%) | Filing |
| 2022-06-10 4:15 pm Purchase | 2022-06-02 | 13D | Acorda Therapeutics, Inc. ACOR | DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 120,165 9.900% | 120,165 (New Position) | Filing |